US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Research & Development Market Research Reports & Industry Analysis

The term research and development (R&D) refers to work that is done in order to better understand the nature, function or understanding of a topic or product in order to gain knowledge and find new applications for existing products or to develop new and innovative products. This is usually performed by corporations, government agencies, and research or academic institutions.

New product design and development is essential for the survival and growth of many companies, as markets and consumers’ tastes are fickle and the competition can be fierce. In order to stay relevant in a fast changing marketplace, firms have to constantly revise and expand their range of product offerings. Therefore, research and development is of great economic importance as companies fight to maintain their market share, though it may mean forgoing current profits in favor of potential future performance and returns.

Research and development is most often associated with the technology industry, as well as with science and in particular with healthcare and the development of new pharmaceuticals, diagnostics or medical devices that are safe and effective. For instance, drug makers must constantly search for the next big blockbuster drug, since the products they currently have on the market will eventually lose their patent protection and be vulnerable to generic competition. So they spend huge amounts of money on R&D because without a promising drug pipeline their revenue stream will ultimately dry up.

RSS Feeds

Research & Development Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Proteins in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 200 drugs. Proteins In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis ...  |  read more...
USD 6,746
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... function. Binding of RANKL to RANK leads to the activation of signaling modules such as NF-kappa B, mitogen activated protein kinases (MAPK's), protein kinase C (PKC), Ca2+/Calcineurin/nuclear factor of activated T cells (NFAT) and phosphatidyl ...  |  read more...
USD 6,746
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... RNA (miRNA, RNAi & siRNA) drugs in 152 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 28 drugs. ...  |  read more...
USD 4,496
Breast Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... below five years. There are today 400 companies plus partners developing 540 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last ...  |  read more...
USD 6,746
Cancer Stem Cells Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 329 companies plus partners developing 448 cancer stem ...  |  read more...
USD 6,746
Cellular Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... years amount to another 65 drugs. Cellular Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 59 different targets. ...  |  read more...
USD 4,496
Cytokine Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... amount to another 11 drugs. Cytokine Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 20 different targets. All ...  |  read more...
USD 4,496
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... and the accumulated number of ceased drugs over the last years amount to another 360 drugs. Egfr1 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each ...  |  read more...
USD 6,746
Gene Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... years amount to another 103 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 107 different targets. ...  |  read more...
USD 6,746
Hematological Cancers Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... projects in cancer. In addition, there are 10 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 290 drugs. Hematological Cancers Drug Pipeline Update lists all drugs and ...  |  read more...
USD 8,996
Global Ankylosing Spondylitis Market 2015-2019
1/7/2015 | published by: TechNavio - Infiniti Research Ltd.
... Ankylosing spondylitis can be diagnosed using clinical signs, radiological signs (sacroiliitis) and the presence of HLA-B27 antigen. According to the NIH and NIAMS, ankylosing spondylitis is a type of arthritis, which affects the joints in ...  |  read more...
USD 3,000
ID Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... of proteins is comprised of IDs 1, 2, 3 and 4. There are today 97 companies plus partners developing 86 ID pathway targeting drugs in 433 developmental projects in cancer. In addition, there is 1 ...  |  read more...
USD 2,246
Leptin Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 217 drugs. Leptin Signaling Pathway In Oncology Drug Pipeline Update lists ...  |  read more...
USD 6,746
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... and the accumulated number of ceased drugs over the last years amount to another 249 drugs. Androgen Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on ...  |  read more...
USD 6,746
Liver Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... another 63 drugs. Liver Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 200 different targets. All included targets have been ...  |  read more...
USD 4,496
Angiogenesis in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... amount to another 207 drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 277 different targets. All included ...  |  read more...
USD 6,746
Lymphoma Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 140 drugs. Lymphoma Drug Pipeline Update lists all drugs and gives you a progress analysis on each one ...  |  read more...
USD 6,746
Neuroendocrine Tumors Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... years amount to another 23 drugs. Neuroendocrine Tumors Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 92 different targets. All included ...  |  read more...
USD 4,496
Antibodies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... of therapeutic antibodies. There are today 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over ...  |  read more...
USD 6,746
Clinical Research (UK) - Industry Report
1/5/2015 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 110 largest Clinical Research (UK) companies. The Clinical Research (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Biologicals in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... in cancer. In addition, there are 26 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1009 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and ...  |  read more...
USD 11,246
Plunkett's Health Care Technologies Overview 2015: A Summary Version of Plunkett's Health Care Industry Almanac 2015
1/7/2015 | published by: Plunkett Research, Ltd.
... Research Online Link to our 5-minute video overview of this industry Pages: 67 Statistical Tables Provided: 34 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2015, including forecasts ...  |  read more...
USD 199.99
Global Overactive Bladder Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... - 2015’. The report provides insights into Overactive Bladder epidemiology, Overactive Bladder diagnosed patients, and Overactive Bladder treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Overactive Bladder ...  |  read more...
USD 1,200
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 295 drugs. Tnf-Alpha Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress ...  |  read more...
USD 6,746
TSH Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... kinases, protein kinase C modules. There are today 179 companies plus partners developing 239 TSH pathway targeting drugs in 1087 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number ...  |  read more...
USD 6,746
< prev 1    3  4  5  6  7  8  9  10